Alternating hemiplegia of childhood is a rare disorder characterized by episodic paroxysmal attacks of neurologic dysfunction and has historically been thought to represent a migraine equivalent, an unusual form of epilepsy, or a movement disorder. Medical treatment with a variety of anticonvulsants and migraine agents is largely unsuccessful, and progressive mental deterioration is universally expected. Despite extensive laboratory studies, the pathophysiologic basis of this condition has thus far eluded identification. Recently, an international workshop was held to generate testable hypotheses regarding the pathophysiology of alternating hemiplegia of childhood. This paper summarizes the major proceedings of that workshop, and hopes to stimulate further interest in elucidating the molecular and cellular mechanisms underlying this unusual disorder. (J Child Neurol 1998;13:39-45).
Get full access to this article
View all access options for this article.
References
1.
Verret S., Steele JC: Alternating hemiplegia in childhood: A report of eight patients with complicated migraine beginning in infancyPediatrics1971 ;47:675-680.
2.
Aicardi J., Bourgeois M., Goutieres F.: Alternating hemiplegia of childhood: Clinical findings and diagnostic criteria , in Andermann F, Aicardi J, Vigevano F (eds): Alternating Hemiplegia of Childhood. New York, Raven Press, 1995, pp 3-18.
3.
Hosking GP, Cavanagh NPC, Wilson J.: Alternating hemiplegia: Complicated migraine of infancy. Arch Dis Child1978;53:656-659.
4.
Andermann F, Aicardi J, Vigevano F (eds): Alternating Hemiplegia of Childhood. New York, Raven Press, 1995.
5.
Hille B.: Ion Channels of Excitable Membranes, 2nd ed. Sunder-land, MA, Sinauer, 1992.
6.
Ptáček LJ: Channelopathies: Ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system. Neuromuscul Disord1997;7:250-255.
7.
Steinlein OK , Mulley JC, Propping P., et al: A missense mutation in the neuronal nicotinic acetylcholine receptor alpha-4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet1995;11:201-203.
8.
Keating MT: The long QT syndrome: A review of recent molecular genetic and physiologic discoveries. Medicine (Baltimore) 1996; 75:1-5.
9.
Ophoff RA, Terwindt GM, Vergouwe MN, et al: Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ gene CACNL1A4. Cell1996;87:543-552.
10.
Mikati MA, Maguire H., Barlow CF, et al: A syndrome of autosomal dominant alternating hemiplegia: Clinical presentation mimicking intractable epilepsy; chromosomal studies and physiologic investigations. Neurol1992;42:2251-2257.
Arnold DL, Silver K., Andermann F.: Evidence for mitochondrial dysfunction in patients with alternating hemiplegia of childhood. Ann Neurol1993;33:604-607.
13.
Kemp GJ, Taylor DJ, Barnes PR, et al: Skeletal muscle mitochondrial dysfunction in alternating hemiplegia of childhood. Ann Neurol1995;38:681-684.
14.
Kyriakides T., Drousiotou A.: No structural or biochemical evidence for mitochondrial cytopathy in a case of alternating hemiplegia of childhood, letter. Ann Neurol1994;36:805-806.
15.
Nevs'imalov'a S., Dittrich J., Havlov'a M., et al: Alternating hemiplegia in childhood: A cross-sectional study. Brain Dev1994;16:189-194.
16.
De Stefano N., Silver K., Andermann F., et al: Mitochondrial dysfunction in patients with alternating hemiplegia of childhood, in Andermann F, Aicardi J, Vigevano F (eds): Alternating Hemiplegia of Childhood. New York, Raven Press , 1995, pp 115-122.
17.
Zupanc ML, Perlman SB, Rust RS: Single photon emission computed tomography studies in alternating hemiplegia of childhood, in Andermann F, Aicardi J, Vigevano F (eds): Alternating Hemiplegia of Childhood. New York, Raven Press, 1995, pp 99-106.
18.
da Silva EA, Chugani DC, Chugani HT: Alternating hemiplegia of childhood: Clinical findings, brain glucose metabolism, and glucose transport studies, abstracted . Ann Neurol1996;40:314.
19.
Wahl M., Schilling L.: Regulation of cerebral blood flow—a brief review. Acta Neurochirurg (Suppl) Wien1993 ;59:3-10.
20.
McLachlan RS : Suppression of spreading depression of Leao in neocortex by an N-methyl-D-aspartate receptor antagonist. Can J Neurol Sci1992;19:487-491.
21.
Marannes R. , Willems R., De Prins E., et al: Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res1988;457:226-240.
22.
Obrenovitch TP, Zilkha E.: Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex. Br J Pharmacol1996;117: 931-937.
23.
Dawson TM, Dawson VL, Snyder SH: A novel neuronal messenger molecule in brain: The free radical, nitric oxide . Ann Neurol1992;32:297-311.
24.
Moncada S., Higgs A.: The L-arginine-nitric oxide pathway. N Engl J Med1993;329:2002-2012.
25.
Olesen J., Thomsen LL, Iversen H.: Nitric oxide is a key molecule in migraine and other vascular headaches . Trends Pharmacol Sci1994;15:149-153.
26.
Collingridge GL, Watkins JC (eds): The NMDA Receptor, 2nd ed. New York, Oxford University Press, 1994.
27.
McDonald JW , Johnston MV: Physiological and pathophysiological roles of excitatory amino acids during central nervous system development . Brain Res Brain Res Rev1990;15:41-70.
28.
Korinthenberg R.: Is infantile alternating hemiplegia mediated by glutamate toxicity and can it be treated with memantine?Neuropediatrics1996;27:277-278.
29.
Casaer P., Azou M.: Flunarizine in alternating hemiplegia in childhood. Lancet1984;2:579.
30.
Casaer P.: Flunarizine in alternating hemiplegia in childhood. An international study in 12 children. Neuropediatrics1987 ;18: 191-195.
31.
Siemes H.: Rectal chloral hydrate for alternating hemiplegia of childhood, letter . Dev Med Child Neurol1990;32:931.
32.
Veneselli E. , Biancheri R.: Alternating hemiplegia of childhood: Treatment of attacks with chloral hydrate and niaprazine, letter. Eur J Pediatr1997;156:157-158.
Hobbs WR, Rall TW, Verdoorn TA: Hypnotics and sedatives: Ethanol, in Hardman JG, Limbard LE, Molinoff PB, et al (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. New York, McGraw Hill, 1996, pp 361-396.
35.
Wibo M., Delfosse I., Godfraind T.: Action of flunarizine and cinnarizine on calcium fluxes in synaptosomal preparations from rat cerebral cortex. Arch Int Pharmacodyn Ther1983;263:333-334.
36.
Binnie CD: Potential antiepileptic drugs. Flunarizine and other calcium entry blockers , in Levy R, Mattson R, Meldrum B, et al (eds): Antiepileptic Drugs, 3rd ed. New York, Raven Press, 1989, pp 971-982.
37.
Parkes JD: The anatomical and physiological basis of the sleep-wake cycle, in Sleep and Its Disorders, Major Problems in Neurology, vol 14. Philadelphia, WB Saunders, 1985, pp 73-118.
38.
Becker LE: Alternating hemiplegia of childhood: A neuropathologic review, in Andermann F, Aicardi J, Vigevano F (eds): Alternating Hemiplegia of Childhood. New York, Raven Press , 1995, pp 57-65.
39.
Brousser MG , Tournier-Lasserve E.: Summary of the proceedings of the First International Workshop on CADASIL. Paris, May 19-21, 1993. Stroke 1994;25:704-707.
40.
Petroff OA, Rothman DL, Behar KL, et al: The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol1996;39:95-99.
